Screener
Vir Biotechnology, Inc. VIR Invested capital
Discontinued — last reported Q2 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Vir Biotechnology, Inc.’s reported figures.
The source filing: Vir Biotechnology, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 5:20 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053549
FAQ
- What is Vir Biotechnology, Inc.'s invested capital?
- Vir Biotechnology, Inc. (VIR) reported invested capital of $788.17M in Q2 2026.
- How has Vir Biotechnology, Inc.'s invested capital changed year-over-year?
- Vir Biotechnology, Inc.'s invested capital increased by 6.0% year-over-year, from $743.42M to $788.17M.
- What is the long-term trend for Vir Biotechnology, Inc.'s invested capital?
- Over 5 years (2020 to 2025), Vir Biotechnology, Inc.'s invested capital has grown at a 12.1% compound annual growth rate (CAGR), from $351.42M to $622.06M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about Vir Biotechnology, Inc.'s invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude